English
简体中文
Total: £ 56.28
Published Date: 2024-10-17 | Pages: 147 | Tables: 264 | Pharma & Healthcare
Drugs made by genetically modified means are also called "biological drugs"
The global market for Genetically Modified Drug was estimated to be worth US$ 2314 million in 2023 and is forecast to a readjusted size of US$ 3481 million by 2030 with a CAGR of 6.0% during the forecast period 2024-2030
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Genetically Modified Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Genetically Modified Drug by region & country, by Type, and by Application.
The Genetically Modified Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetically Modified Drug.
Market Segmentation
By Company
LFB Biotechnologies SA
Pharming Group NV
Pfizer
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Amgen
F. Hoffmann-La Roche
Sanofi
Novartis
Eli Lilly
Takeda
Baxter
GlaxoSmithKline
Segment by Type:
Transgenic Animal
Transgenic Plant
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Genetically Modified Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Genetically Modified Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Genetically Modified Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Genetically Modified Drug Product Introduction
1.2 Global Genetically Modified Drug Market Size Forecast
1.2.1 Global Genetically Modified Drug Sales Value (2019-2030)
1.2.2 Global Genetically Modified Drug Sales Volume (2019-2030)
1.2.3 Global Genetically Modified Drug Sales Price (2019-2030)
1.3 Genetically Modified Drug Market Trends & Drivers
1.3.1 Genetically Modified Drug Industry Trends
1.3.2 Genetically Modified Drug Market Drivers & Opportunity
1.3.3 Genetically Modified Drug Market Challenges
1.3.4 Genetically Modified Drug Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Genetically Modified Drug Players Revenue Ranking (2023)
2.2 Global Genetically Modified Drug Revenue by Company (2019-2024)
2.3 Global Genetically Modified Drug Players Sales Volume Ranking (2023)
2.4 Global Genetically Modified Drug Sales Volume by Company Players (2019-2024)
2.5 Global Genetically Modified Drug Average Price by Company (2019-2024)
2.6 Key Manufacturers Genetically Modified Drug Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Genetically Modified Drug Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Genetically Modified Drug
2.9 Genetically Modified Drug Market Competitive Analysis
2.9.1 Genetically Modified Drug Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Genetically Modified Drug Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetically Modified Drug as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Transgenic Animal
3.1.2 Transgenic Plant
3.2 Global Genetically Modified Drug Sales Value by Type
3.2.1 Global Genetically Modified Drug Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Genetically Modified Drug Sales Value, by Type (2019-2030)
3.2.3 Global Genetically Modified Drug Sales Value, by Type (%) (2019-2030)
3.3 Global Genetically Modified Drug Sales Volume by Type
3.3.1 Global Genetically Modified Drug Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Genetically Modified Drug Sales Volume, by Type (2019-2030)
3.3.3 Global Genetically Modified Drug Sales Volume, by Type (%) (2019-2030)
3.4 Global Genetically Modified Drug Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Genetically Modified Drug Sales Value by Application
4.2.1 Global Genetically Modified Drug Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Genetically Modified Drug Sales Value, by Application (2019-2030)
4.2.3 Global Genetically Modified Drug Sales Value, by Application (%) (2019-2030)
4.3 Global Genetically Modified Drug Sales Volume by Application
4.3.1 Global Genetically Modified Drug Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Genetically Modified Drug Sales Volume, by Application (2019-2030)
4.3.3 Global Genetically Modified Drug Sales Volume, by Application (%) (2019-2030)
4.4 Global Genetically Modified Drug Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Genetically Modified Drug Sales Value by Region
5.1.1 Global Genetically Modified Drug Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Genetically Modified Drug Sales Value by Region (2019-2024)
5.1.3 Global Genetically Modified Drug Sales Value by Region (2025-2030)
5.1.4 Global Genetically Modified Drug Sales Value by Region (%), (2019-2030)
5.2 Global Genetically Modified Drug Sales Volume by Region
5.2.1 Global Genetically Modified Drug Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Genetically Modified Drug Sales Volume by Region (2019-2024)
5.2.3 Global Genetically Modified Drug Sales Volume by Region (2025-2030)
5.2.4 Global Genetically Modified Drug Sales Volume by Region (%), (2019-2030)
5.3 Global Genetically Modified Drug Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Genetically Modified Drug Sales Value, 2019-2030
5.4.2 North America Genetically Modified Drug Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Genetically Modified Drug Sales Value, 2019-2030
5.5.2 Europe Genetically Modified Drug Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Genetically Modified Drug Sales Value, 2019-2030
5.6.2 Asia Pacific Genetically Modified Drug Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Genetically Modified Drug Sales Value, 2019-2030
5.7.2 South America Genetically Modified Drug Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Genetically Modified Drug Sales Value, 2019-2030
5.8.2 Middle East & Africa Genetically Modified Drug Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Genetically Modified Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Genetically Modified Drug Sales Value
6.2.1 Key Countries/Regions Genetically Modified Drug Sales Value, 2019-2030
6.2.2 Key Countries/Regions Genetically Modified Drug Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Genetically Modified Drug Sales Value, 2019-2030
6.3.2 United States Genetically Modified Drug Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Genetically Modified Drug Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Genetically Modified Drug Sales Value, 2019-2030
6.4.2 Europe Genetically Modified Drug Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Genetically Modified Drug Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Genetically Modified Drug Sales Value, 2019-2030
6.5.2 China Genetically Modified Drug Sales Value by Type (%), 2023 VS 2030
6.5.3 China Genetically Modified Drug Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Genetically Modified Drug Sales Value, 2019-2030
6.6.2 Japan Genetically Modified Drug Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Genetically Modified Drug Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Genetically Modified Drug Sales Value, 2019-2030
6.7.2 South Korea Genetically Modified Drug Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Genetically Modified Drug Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Genetically Modified Drug Sales Value, 2019-2030
6.8.2 Southeast Asia Genetically Modified Drug Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Genetically Modified Drug Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Genetically Modified Drug Sales Value, 2019-2030
6.9.2 India Genetically Modified Drug Sales Value by Type (%), 2023 VS 2030
6.9.3 India Genetically Modified Drug Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 LFB Biotechnologies SA
7.1.1 LFB Biotechnologies SA Company Information
7.1.2 LFB Biotechnologies SA Introduction and Business Overview
7.1.3 LFB Biotechnologies SA Genetically Modified Drug Sales, Revenue and Gross Margin (2019-2024)
7.1.4 LFB Biotechnologies SA Genetically Modified Drug Product Offerings
7.1.5 LFB Biotechnologies SA Recent Development
7.2 Pharming Group NV
7.2.1 Pharming Group NV Company Information
7.2.2 Pharming Group NV Introduction and Business Overview
7.2.3 Pharming Group NV Genetically Modified Drug Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Pharming Group NV Genetically Modified Drug Product Offerings
7.2.5 Pharming Group NV Recent Development
7.3 Pfizer
7.3.1 Pfizer Company Information
7.3.2 Pfizer Introduction and Business Overview
7.3.3 Pfizer Genetically Modified Drug Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Pfizer Genetically Modified Drug Product Offerings
7.3.5 Pfizer Recent Development
7.4 Roche
7.4.1 Roche Company Information
7.4.2 Roche Introduction and Business Overview
7.4.3 Roche Genetically Modified Drug Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Roche Genetically Modified Drug Product Offerings
7.4.5 Roche Recent Development
7.5 Abbott Laboratories
7.5.1 Abbott Laboratories Company Information
7.5.2 Abbott Laboratories Introduction and Business Overview
7.5.3 Abbott Laboratories Genetically Modified Drug Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Abbott Laboratories Genetically Modified Drug Product Offerings
7.5.5 Abbott Laboratories Recent Development
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Information
7.6.2 Johnson & Johnson Introduction and Business Overview
7.6.3 Johnson & Johnson Genetically Modified Drug Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Johnson & Johnson Genetically Modified Drug Product Offerings
7.6.5 Johnson & Johnson Recent Development
7.7 Merck & Co.
7.7.1 Merck & Co. Company Information
7.7.2 Merck & Co. Introduction and Business Overview
7.7.3 Merck & Co. Genetically Modified Drug Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Merck & Co. Genetically Modified Drug Product Offerings
7.7.5 Merck & Co. Recent Development
7.8 Amgen
7.8.1 Amgen Company Information
7.8.2 Amgen Introduction and Business Overview
7.8.3 Amgen Genetically Modified Drug Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Amgen Genetically Modified Drug Product Offerings
7.8.5 Amgen Recent Development
7.9 F. Hoffmann-La Roche
7.9.1 F. Hoffmann-La Roche Company Information
7.9.2 F. Hoffmann-La Roche Introduction and Business Overview
7.9.3 F. Hoffmann-La Roche Genetically Modified Drug Sales, Revenue and Gross Margin (2019-2024)
7.9.4 F. Hoffmann-La Roche Genetically Modified Drug Product Offerings
7.9.5 F. Hoffmann-La Roche Recent Development
7.10 Sanofi
7.10.1 Sanofi Company Information
7.10.2 Sanofi Introduction and Business Overview
7.10.3 Sanofi Genetically Modified Drug Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Sanofi Genetically Modified Drug Product Offerings
7.10.5 Sanofi Recent Development
7.11 Novartis
7.11.1 Novartis Company Information
7.11.2 Novartis Introduction and Business Overview
7.11.3 Novartis Genetically Modified Drug Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Novartis Genetically Modified Drug Product Offerings
7.11.5 Novartis Recent Development
7.12 Eli Lilly
7.12.1 Eli Lilly Company Information
7.12.2 Eli Lilly Introduction and Business Overview
7.12.3 Eli Lilly Genetically Modified Drug Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Eli Lilly Genetically Modified Drug Product Offerings
7.12.5 Eli Lilly Recent Development
7.13 Takeda
7.13.1 Takeda Company Information
7.13.2 Takeda Introduction and Business Overview
7.13.3 Takeda Genetically Modified Drug Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Takeda Genetically Modified Drug Product Offerings
7.13.5 Takeda Recent Development
7.14 Baxter
7.14.1 Baxter Company Information
7.14.2 Baxter Introduction and Business Overview
7.14.3 Baxter Genetically Modified Drug Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Baxter Genetically Modified Drug Product Offerings
7.14.5 Baxter Recent Development
7.15 GlaxoSmithKline
7.15.1 GlaxoSmithKline Company Information
7.15.2 GlaxoSmithKline Introduction and Business Overview
7.15.3 GlaxoSmithKline Genetically Modified Drug Sales, Revenue and Gross Margin (2019-2024)
7.15.4 GlaxoSmithKline Genetically Modified Drug Product Offerings
7.15.5 GlaxoSmithKline Recent Development
8 Industry Chain Analysis
8.1 Genetically Modified Drug Industrial Chain
8.2 Genetically Modified Drug Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Genetically Modified Drug Sales Model
8.5.2 Sales Channel
8.5.3 Genetically Modified Drug Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Genetically Modified Drug Market Trends
Table 2. Genetically Modified Drug Market Drivers & Opportunity
Table 3. Genetically Modified Drug Market Challenges
Table 4. Genetically Modified Drug Market Restraints
Table 5. Global Genetically Modified Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Genetically Modified Drug Revenue Market Share by Company (2019-2024)
Table 7. Global Genetically Modified Drug Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Genetically Modified Drug Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Genetically Modified Drug Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Genetically Modified Drug Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Genetically Modified Drug Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Genetically Modified Drug
Table 13. Global Genetically Modified Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetically Modified Drug as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Genetically Modified Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Genetically Modified Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Genetically Modified Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Genetically Modified Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Genetically Modified Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Genetically Modified Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Genetically Modified Drug Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Genetically Modified Drug Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Genetically Modified Drug Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Genetically Modified Drug Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Genetically Modified Drug Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Genetically Modified Drug Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Genetically Modified Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Genetically Modified Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Genetically Modified Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Genetically Modified Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Genetically Modified Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Genetically Modified Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Genetically Modified Drug Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Genetically Modified Drug Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Genetically Modified Drug Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Genetically Modified Drug Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Genetically Modified Drug Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Genetically Modified Drug Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Genetically Modified Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Genetically Modified Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Genetically Modified Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Genetically Modified Drug Sales Value by Region (2019-2024) & (%)
Table 44. Global Genetically Modified Drug Sales Value by Region (2025-2030) & (%)
Table 45. Global Genetically Modified Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Genetically Modified Drug Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Genetically Modified Drug Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Genetically Modified Drug Sales Volume by Region (2019-2024) & (%)
Table 49. Global Genetically Modified Drug Sales Volume by Region (2025-2030) & (%)
Table 50. Global Genetically Modified Drug Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Genetically Modified Drug Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Genetically Modified Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Genetically Modified Drug Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Genetically Modified Drug Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Genetically Modified Drug Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Genetically Modified Drug Sales Volume, (2025-2030) & (K Units)
Table 57. LFB Biotechnologies SA Company Information
Table 58. LFB Biotechnologies SA Introduction and Business Overview
Table 59. LFB Biotechnologies SA Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. LFB Biotechnologies SA Genetically Modified Drug Product Offerings
Table 61. LFB Biotechnologies SA Recent Development
Table 62. Pharming Group NV Company Information
Table 63. Pharming Group NV Introduction and Business Overview
Table 64. Pharming Group NV Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Pharming Group NV Genetically Modified Drug Product Offerings
Table 66. Pharming Group NV Recent Development
Table 67. Pfizer Company Information
Table 68. Pfizer Introduction and Business Overview
Table 69. Pfizer Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Pfizer Genetically Modified Drug Product Offerings
Table 71. Pfizer Recent Development
Table 72. Roche Company Information
Table 73. Roche Introduction and Business Overview
Table 74. Roche Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Roche Genetically Modified Drug Product Offerings
Table 76. Roche Recent Development
Table 77. Abbott Laboratories Company Information
Table 78. Abbott Laboratories Introduction and Business Overview
Table 79. Abbott Laboratories Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Abbott Laboratories Genetically Modified Drug Product Offerings
Table 81. Abbott Laboratories Recent Development
Table 82. Johnson & Johnson Company Information
Table 83. Johnson & Johnson Introduction and Business Overview
Table 84. Johnson & Johnson Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Johnson & Johnson Genetically Modified Drug Product Offerings
Table 86. Johnson & Johnson Recent Development
Table 87. Merck & Co. Company Information
Table 88. Merck & Co. Introduction and Business Overview
Table 89. Merck & Co. Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Merck & Co. Genetically Modified Drug Product Offerings
Table 91. Merck & Co. Recent Development
Table 92. Amgen Company Information
Table 93. Amgen Introduction and Business Overview
Table 94. Amgen Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Amgen Genetically Modified Drug Product Offerings
Table 96. Amgen Recent Development
Table 97. F. Hoffmann-La Roche Company Information
Table 98. F. Hoffmann-La Roche Introduction and Business Overview
Table 99. F. Hoffmann-La Roche Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. F. Hoffmann-La Roche Genetically Modified Drug Product Offerings
Table 101. F. Hoffmann-La Roche Recent Development
Table 102. Sanofi Company Information
Table 103. Sanofi Introduction and Business Overview
Table 104. Sanofi Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Sanofi Genetically Modified Drug Product Offerings
Table 106. Sanofi Recent Development
Table 107. Novartis Company Information
Table 108. Novartis Introduction and Business Overview
Table 109. Novartis Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Novartis Genetically Modified Drug Product Offerings
Table 111. Novartis Recent Development
Table 112. Eli Lilly Company Information
Table 113. Eli Lilly Introduction and Business Overview
Table 114. Eli Lilly Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Eli Lilly Genetically Modified Drug Product Offerings
Table 116. Eli Lilly Recent Development
Table 117. Takeda Company Information
Table 118. Takeda Introduction and Business Overview
Table 119. Takeda Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Takeda Genetically Modified Drug Product Offerings
Table 121. Takeda Recent Development
Table 122. Baxter Company Information
Table 123. Baxter Introduction and Business Overview
Table 124. Baxter Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Baxter Genetically Modified Drug Product Offerings
Table 126. Baxter Recent Development
Table 127. GlaxoSmithKline Company Information
Table 128. GlaxoSmithKline Introduction and Business Overview
Table 129. GlaxoSmithKline Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. GlaxoSmithKline Genetically Modified Drug Product Offerings
Table 131. GlaxoSmithKline Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Genetically Modified Drug Downstream Customers
Table 135. Genetically Modified Drug Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Genetically Modified Drug Product Picture
Figure 2. Global Genetically Modified Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Genetically Modified Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Genetically Modified Drug Sales Volume (2019-2030) & (K Units)
Figure 5. Global Genetically Modified Drug Sales Price (2019-2030) & (US$/Unit)
Figure 6. Genetically Modified Drug Report Years Considered
Figure 7. Global Genetically Modified Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Genetically Modified Drug Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Genetically Modified Drug Revenue in 2023
Figure 10. Genetically Modified Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Transgenic Animal Picture
Figure 12. Transgenic Plant Picture
Figure 13. Global Genetically Modified Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Genetically Modified Drug Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Genetically Modified Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Genetically Modified Drug Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Genetically Modified Drug Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Clinic
Figure 20. Global Genetically Modified Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Genetically Modified Drug Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Genetically Modified Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 23. Global Genetically Modified Drug Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Genetically Modified Drug Price by Application (2019-2030) & (US$/Unit)
Figure 25. North America Genetically Modified Drug Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Genetically Modified Drug Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Genetically Modified Drug Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Genetically Modified Drug Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Genetically Modified Drug Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Genetically Modified Drug Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Genetically Modified Drug Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Genetically Modified Drug Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Genetically Modified Drug Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Genetically Modified Drug Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Genetically Modified Drug Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Genetically Modified Drug Sales Volume (%), (2019-2030)
Figure 37. United States Genetically Modified Drug Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Genetically Modified Drug Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Genetically Modified Drug Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Genetically Modified Drug Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Genetically Modified Drug Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Genetically Modified Drug Sales Value by Application (%), 2023 VS 2030
Figure 43. China Genetically Modified Drug Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Genetically Modified Drug Sales Value by Type (%), 2023 VS 2030
Figure 45. China Genetically Modified Drug Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Genetically Modified Drug Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Genetically Modified Drug Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Genetically Modified Drug Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Genetically Modified Drug Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Genetically Modified Drug Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Genetically Modified Drug Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Genetically Modified Drug Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Genetically Modified Drug Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Genetically Modified Drug Sales Value by Application (%), 2023 VS 2030
Figure 55. India Genetically Modified Drug Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Genetically Modified Drug Sales Value by Type (%), 2023 VS 2030
Figure 57. India Genetically Modified Drug Sales Value by Application (%), 2023 VS 2030
Figure 58. Genetically Modified Drug Industrial Chain
Figure 59. Genetically Modified Drug Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
